Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × Surgical Procedures, Operative × NET × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

CNS 6 Gastrointestinal 3 Tumor-Agnostic 2 Breast 2 Sarcoma 1 NET 1 Genitourinary 1 Endocrine 1 Dermatologic 1

Conditions

Neuroendocrine Tumors 1 Neoplasm Metastasis 1

Interventions

Everolimus 3 tislelizumab 1 surufatinib 1 regorafenib 1 pasireotide 1 lutetium Lu 177 dotatate 1 fludarabine phosphate 1 epothilone B 1 cixutumumab 1 Surgical Procedures, Operative 1 Sunitinib 1 Specimen Handling 1 Radiosurgery 1 Octreotide 1 Magnetic Resonance Spectroscopy 1 Liver Transplantation 1 LY2584702 1 Interleukin-13 1 Fluorodeoxyglucose F18 1 Erlotinib Hydrochloride 1 Embolization, Therapeutic 1 Doxorubicin 1 Cyclophosphamide 1 Cryosurgery 1 Clinical Trials, Phase II as Topic 1 Chemoembolization, Therapeutic 1 Biopsy 1 3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04066322 2019-09-24

RMPanNET

Fudan University

Neoplasm Metastasis, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡